Boess FG, Monsma FJ Jr, and Sleight AJ (1998) Identification of residues in transmembrane regions III and IV that contribute to the ligand binding site of the
serotonin 5-HT6 receptor. J Neurochem 71:2169 –2177.
Bourson A, Borroni E, Austin RH, Monsma FJ Jr, and Sleight AJ (1995) Determination of the role of the 5-HT6 receptor in the rat brain: a study using antisense
oligonucleotides. J Pharmacol Exp Ther 274:173–180.
Bowen WP and Jerman JC (1995) Nonlinear regression using spreadsheets. Trends
Pharmacol Sci 16:413– 417.
Bromidge SM, Brown AM, Clarke SE, Dodgson K, Gager T, Grassam HL, Jeffrey PM,
Joiner GF, King FD, Middlemiss DN, et al. (1999) 5-Chloro-N-(4-methoxy-3- piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046): a po- tent, selective, and orally bioavailable 5-HT6 receptor antagonist. J Med Chem
42:202–205.
Bromidge SM, Clarke SE, Gager T, Griffith K, Jeffrey P, Jennings AJ, Joiner GF,
King FD, Lovell PJ, Moss SF, et al. (2001) Phenyl benzenesulfonamides are novel
and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)- 4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134). Bioorg Med Chem
Lett 11:55–58.
Cheng YC and Prusoff WH (1973) Relationship between inhibition constant (Ki) and
the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic
reaction. Biochem Pharmacol 92:881– 894.
Dunbrack RL Jr (2002) Rotamer libraries in the 21st century. Curr Opin Struct Biol
12:431– 440.
East SZ, Burnet PWJ, Leslie RA, Roberts JC, and Harrison PJ (2002) 5-HT6 receptor
binding sites in schizophrenia and following antipsychotic drug administration:
autoradiographic studies with [125I]SB-258585. Synapse 45:191–199.
FunkeW (1982) Proton and carbon-13 NMR spectra of mianserin and 10- hydroxymianserin derivatives in solution. Spectral assignments and conformational conclusions. J R Neth Chem Soc 101:437– 440.
Gerard C, Martres MP, Lefevre K, Miquel MC, Verge ́ D, Lanumey L, Doucet E,
Hamon M, and El Mestikawy S (1997) Immunolocalization of serotonin 5-HT6
receptor-like material in the rat central nervous system. Brain Res 746:207–219.
Grimaldi B, Sibella-Arguelles C, Bonnin A, Fillion MP, Massot O, Rousselle JC,
Seznec JC, and Fillion G (1998) Functional properties of 5-HT-moduline in the
immune system: a model for central nervous system investigation. Ann NY Acad
Sci 861:249 –250.
Hamon M, Doucet E, Lefevre K, Miquel MC, Lanfumey L, Insausti R, Frechilla D,
Del Rio J, and Verge D (1998) Antibodies and antisense oligonucleotide for probing
the distribution and putative functions of central 5-HT6 receptors. Neuropsychopharmacology 21:68 –76.
Hirst WD, Abrahamsen BA, Blaney FE, Calver AR, Aloj L, Price GW, and Medhurst
AD (2002) Mouse 5-HT6 receptors: a distinct pharmacological profile from rat and
human. Soc Neurosci Abstr 31:641.10.
Hirst WD, Minton JAL, Bromidge SM, Moss SF, Latter AJ, Riley G, Routledge C,
Middlemiss DN, and Price GW (2000) Characterization of [125I]-SB-258585 binding to human recombinant and native 5-HT6 receptors in rat, pig and human brain
tissue. Br J Pharmacol 130:1597–1605.
Kohen R, Fashingbauer LA, Heidmann DE, Guthrie CR, and Hamblin MW (2001)
Cloning of the mouse 5-HT6 serotonin receptor and mutagenesis studies of the
third intracellular loop. Brain Res Mol Brain Res 90:110 –117.
Kohen R, Metcalf MA, Khan N, Druck T, Huebner K, and Sibley DR (1996) Cloning,
characterization and chromosomal localization of a human 5-HT6 serotonin receptor. J Neurochem 66:47–56.
Kristiansen K, Kroeze WK, Willins DL, Gelber EI, Savage JE, Glennon RA, and Roth
BL (2000) A highly conserved aspartic acid (Asp-155) anchors the terminal amine
moiety of tryptamines and is involved in membrane targeting of the 5-HT2A
serotonin receptor but does not participate in activation via a “salt bridge disruption” mechanism. J Pharmacol Exp Ther 293:735–746.
Kyte J and Doolittle RF (1982) A simple method for displaying the hydropathic
character of a protein. J Mol Biol 157:105–132.
Medhurst AD, Harrison DC, Read SJ, Campbell CA, Robbins MJ, and Pangalos MN
(2000) The use of TaqMan RT-PCR assays for quantification of gene expression in
CNS tissues and disease models. J Neurosci Method 98:9 –20.
Medhurst AD, Hirst WD, Jerman JC, Meakin J, Roberts JC, Testa T, and Smart D
(1999) Molecular and pharmacological characterization of a functional tachykinin
NK3 receptor cloned from the rabbit iris sphincter muscle. Br J Pharmacol 128:
627– 636.
